Abeona Therapeutics (ABEO) Receivables (2010 - 2026)
Abeona Therapeutics' (ABEO) quarterly Receivables came in at $6.6 million in Q1 2026, up 308.16% year-on-year from $1.6 million in Q1 2025, and up 729.77% quarter-over-quarter from -$1.0 million in Q4 2025.
Abeona Therapeutics (ABEO) Receivables (2010 - 2026) Analysis & Trends
Abeona Therapeutics' Receivables history runs 17 years deep, the most recent figure standing at $6.6 million for Q1 2026.
- On a quarterly basis, Receivables rose 308.16% year-over-year to $6.6 million in Q1 2026; TTM through Mar 2026 was $6.6 million, a 308.16% increase from a year earlier, with the FY2025 full-year figure at $5.1 million, up 206.48% from the prior year.
- Receivables climbed to $6.6 million in Q1 2026 per ABEO's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Receivables topped out at $6.6 million in Q1 2026 and bottomed at -$1.0 million in Q4 2025.
- The 5-year median for Receivables is $1.6 million (2024), against an average of $1.9 million.
- Across the five-year window, Receivables surged 1200.0% in 2023 and sank 2787.17% in 2025, its largest moves.
- Year by year, Receivables stood at $188000.0 in 2022, then jumped by 1200.0% to $2.4 million in 2023, then sank by 98.4% to $39000.0 in 2024, then sank by 2787.17% to -$1.0 million in 2025, then surged by 729.77% to $6.6 million in 2026.
- Per Business Quant, the three latest ABEO Receivables figures stand at $6.6 million (Q1 2026), -$1.0 million (Q4 2025), and $1.6 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn | 6.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | -1.05 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 39,000.00 |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 2.23 Mn |
| Dec 31, 2023 | 2.44 Mn |
| Sep 30, 2023 | 2.10 Mn |
| Jun 30, 2023 | 5.73 Mn |
| Dec 31, 2022 | 188,000.00 |
| Sep 30, 2022 | 267,000.00 |
| Jun 30, 2022 | 1.50 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2020 | 14.00 Mn |
| Sep 30, 2019 | 15,000.00 |
| Jun 30, 2019 | 40,000.00 |
| Mar 31, 2019 | 38,000.00 |